Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
15 Mayo 2023 - 6:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2023
Commission File Number 000-30902
(Translation of registrant's name into English)
26 Harokmim Street
Holon 5885849, Israel
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or
Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(7): ☐
Compugen Ltd.
On May 15, 2023, Compugen Ltd. (the “Company”) issued a press release reporting the Company’s first quarter
2023 results (the “Press Release”), a copy of which is furnished as Exhibit 99.1 to this Report on Form 6-K.
With the exception of the quotes attributable to Anat Cohen-Dayag, Ph.D., information contained in the
Press Release is hereby incorporated by reference into the Company’s Registration Statements on Form F-3, File Nos. 333-240183 and 333-270985.
Exhibits
|
Exhibit
|
|
|
Number
|
Description of Exhibit
|
| |
|
|
|
|
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
COMPUGEN LTD.
|
|
| |
|
Date: May 15, 2023
|
By:
|
/s/ Eran Ben Dor
|
|
| |
|
Eran Ben Dor
|
|
| |
|
General Counsel
|
|
Compugen (NASDAQ:CGEN)
Gráfica de Acción Histórica
De Ene 2025 a Feb 2025
Compugen (NASDAQ:CGEN)
Gráfica de Acción Histórica
De Feb 2024 a Feb 2025
